Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition
Authors:
- Pottathil ShinuPSPottathil Shinu
- Manu SharmaMSManu Sharma
- Girdhari Lal GuptaGGGirdhari Lal Gupta
- Somdutt MujwarSMSomdutt Mujwar
- Mahmoud KandeelMahmoud Kandeel
- Manish KumarMKManish Kumar
- Anroop B. NairANAnroop B. Nair
- Manoj GoyalMGManoj Goyal
- Purna SinghPSPurna Singh
- Mahesh AttimaradMAMahesh Attimarad
- Katharigatta N. VenugopalaKatharigatta N. Venugopala
- Sreeharsha NagarajaSreeharsha Nagaraja
Open Access
Abstract
The 4-allyl guaiacol is a natural phenolic molecule that has been widely studied for its antioxidant capacity against reactive-oxygen-species-mediated cellular damage. Therefore, we hypothesized that concomitant use of an antioxidant and NSAID may decrease the risk of gastrointestinal toxicity and make the therapy safer. To address the gastrointestinal toxicity of conventional NSAIDs, a new S-naproxen-4-allyl guaiacol chimera (MAS-1696) was computationally developed, chemically synthesized, and tested for anti-inflammatory effectiveness and gastrointestinal safety. The inhibitory potency of MAS-1696 tested against cyclooxygenase-2 (COX2), 15-lipoxygenase-2 (15-LOX2), and lipoxygenase-5 (5-LOX) in vitro revealed a stronger inhibition of COX2. Furthermore, the MAS-1696 chimera increased the COX selectivity index by 23% as compared to the parent compound naproxen, implying higher efficacy and gastric safety. In vivo data showed that MAS-1696 was less likely to cause gastrointestinal harm than naproxen while also exerting anti-inflammatory and analgesic effects equivalent to or superior to naproxen. In conclusion, MAS-1696 is orally active, bio-labile, and crystalline, making it a medication that may be administered orally.Keywords
Funding Information
- King Faisal University (GRANT1007)
This publication has 53 references indexed in Scilit:
- The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestineJournal of Clinical Biochemistry and Nutrition, 2011
- Assessment of Antioxidant Activity of Eugenol In Vitro and In Vivo2009
- Review article: cellular and molecular mechanisms of NSAID‐induced peptic ulcersAlimentary Pharmacology & Therapeutics, 2009
- 5-Lipoxygenase: mechanisms of regulationJournal of Lipid Research, 2009
- Role of nitric oxide in the gastrointestinal tractArthritis Research & Therapy, 2008
- Modulation of indomethacin‐induced gastric injury by spermine and taurine in ratsJournal of Biochemical and Molecular Toxicology, 2007
- Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyondBritish Journal of Clinical Pharmacology, 2004
- NO‐naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritisBritish Journal of Pharmacology, 2000
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1985